test

Mark N. Lampert

@Bvf Inc Il

Latest period2024 - Q3ReportedManaged Assets$3.418BTotal holdings55
Assets growth rate-4.19%Assets growth rate (2-Q avg)-3.05%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Bvf Inc Il's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 55 positions.

Assets under management

The assets under management (AUM) of Bvf Inc Il over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.418B in assets, with a quarterly growth rate of -4.19% and a 2-quarter average growth rate of -3.05%. The portfolio is managed by Mark N. Lampert, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
MRUSMerus N V
Recent Activity
Exited
0%
$75.681M
1.279M shares@ $59.17 avg price
CALTCalliditas Therapeutics Ab
Recent Activity
Exited
0%
$29.242M
750,000 shares@ $38.99 avg price
ROIVRoivant Sciences Ltd
Recent Activity
Exited
0%
$28.987M
2.742M shares@ $10.57 avg price
JANXJanux Therapeutics Inc
Recent Activity
Exited
0%
$18.496M
441,528 shares@ $41.9 avg price
VIRXViracta Therapeutics Inc
Recent Activity
Exited
0%
$1.965M
3.615M shares@ $0.55 avg price
FBRXForte Biosciences Inc
Recent Activity
Exited
0%
$1.601M
2.982M shares@ $0.54 avg price
NLSPWNls Pharmaceutics Ltd
Recent Activity
Exited
0%
$1.247M
5.747M shares@ $0.22 avg price
UNCYUnicycive Therapeutics Inc
Recent Activity
Exited
0%
$1.102M
2.2M shares@ $0.51 avg price
RZLTRezolute Inc
Recent Activity
Exited
0%
$820,505
190,815 shares@ $4.31 avg price
ASLNAslan Pharmaceuticals Ltd
Recent Activity
Exited
0%
$315,000
1.05M shares@ $0.31 avg price